Characterization of a canine model of autosomal recessive retinitis pigmentosa due to a PDE6A mutation.
OBJECTIVE
To characterize a canine model of autosomal recessive RP due to a PDE6A gene mutation.


METHODS
Affected and breed- and age-matched control puppies were studied by electroretinography (ERG), light and electron microscopy, immunohistochemistry, and assay for retinal PDE6 levels and enzymatic activity.


RESULTS
The mutant puppies failed to develop normal rod-mediated ERG responses and had reduced light-adapted a-wave amplitudes from an early age. The residual ERG waveforms originated primarily from cone-driven responses. Development of photoreceptor outer segments stopped, and rod cells were lost by apoptosis. Immunohistochemistry demonstrated a marked reduction in rod opsin immunostaining outer segments and relative preservation of cones early in the disease process. With exception of rod bipolar cells, which appeared to be reduced in number relatively early in the disease process, other inner retinal cells were preserved in the early stages of the disease, although there was marked and early activation of Müller glia. Western blot analysis showed that the PDE6A mutation not only resulted in a lack of PDE6A protein but the affected retinas also lacked the other PDE6 subunits, suggesting expression of PDE6A is essential for normal expression of PDE6B and PDE6G. Affected retinas lacked PDE6 enzymatic activity.


CONCLUSIONS
This represents the first characterization of a PDE6A model of autosomal recessive retinitis pigmentosa, and the PDE6A mutant dog shows promise as a large animal model for investigation of therapies to rescue mutant rod photoreceptors and to preserve cone photoreceptors in the face of a rapid loss of rod cells.
Tuntivanich
Nalinee
N
Department of Small Animal Clinical Studies, Michigan State University, East Lansing, Michigan 48824, USA.
Pittler
Steven J
SJ
Fischer
Andy J
AJ
Omar
Ghezal
G
Kiupel
Matti
M
Weber
Arthur
A
Yao
Suxia
S
Steibel
Juan Pedro
JP
Khan
Naheed Wali
NW
Petersen-Jones
Simon M
SM
D000818:Animals; D015153:Blotting, Western / Q000662:veterinary; D001947:Breeding; D054707:Cyclic Nucleotide Phosphodiesterases, Type 6 / Q000235:genetics*; D004195:Disease Models, Animal; D004283:Dog Diseases / Q000235:genetics* / Q000503:physiopathology; D004285:Dogs; D004596:Electroretinography / Q000662:veterinary; D005260:Female; D005808:Genes, Recessive; D007150:Immunohistochemistry / Q000662:veterinary; D020287:In Situ Nick-End Labeling; D008297:Male; D017354:Point Mutation; D012160:Retina / Q000503:physiopathology; D012174:Retinitis Pigmentosa / Q000235:genetics / Q000503:physiopathology / Q000662:veterinary*
D054707:Cyclic Nucleotide Phosphodiesterases, Type 6
Cytogenet Cell Genet. 2000;90(3-4):261-7
11124530
Exp Eye Res. 1980 May;30(5):575-91
7409013
Hum Mol Genet. 2001 Oct 1;10(20):2269-75
11673410
Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1669-81
16565408
Mol Vis. 2001 Feb 25;7:42-7
11239245
Proc Natl Acad Sci U S A. 1993 May 1;90(9):3968-72
8387203
J Biol Chem. 1992 Apr 25;267(12):8458-63
1314827
Mol Vis. 2006 Oct 26;12:1283-91
17110911
Exp Eye Res. 1986 Apr;42(4):363-73
2423355
DNA. 1989 Jul-Aug;8(6):437-46
2776627
Neuron. 1993 Oct;11(4):595-605
8398150
Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1859-65
10393062
Vis Neurosci. 2005 Nov-Dec;22(6):721-34
16469183
J Neurosci. 2003 Jul 2;23(13):5723-31
12843276
Curr Eye Res. 1993 Sep;12(9):861-6
8261797
J Neural Eng. 2005 Mar;2(1):S65-73
15876657
Vision Res. 2002 Feb;42(4):439-45
11853759
Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13897-902
15365178
Vis Neurosci. 1999 Mar-Apr;16(2):391-8
10367972
Vision Res. 2003 Apr;43(8):879-85
12668057
Mol Cell Neurosci. 2001 Oct;18(4):335-46
11640892
Exp Eye Res. 1988 Feb;46(2):149-59
2895011
J Am Vet Med Assoc. 1975 Jan 15;166(2):157-64
1112740
Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1637-44
10393029
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11020-5
10995468
Science. 1996 May 17;272(5264):1026-9
8638127
J Biol Chem. 1979 Nov 25;254(22):11669-77
227876
J Neurosci. 2005 May 4;25(18):4540-9
15872101
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12630-5
14555765
Science. 1974 Nov 1;186(4162):449-51
4369896
Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13903-8
15365173
Invest Ophthalmol Vis Sci. 1988 Sep;29(9):1363-71
3417421
Exp Eye Res. 1982 Dec;35(6):625-42
6295790
Mol Vis. 2004 Oct 06;10:738-49
15480303
Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2878-87
18408180
Nat Genet. 1995 Dec;11(4):468-71
7493036
Doc Ophthalmol. 2005 Sep;111(2):95-106
16514491
Bioessays. 2001 Jul;23(7):605-18
11462214
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9340-4
8415703
Invest Ophthalmol Vis Sci. 2004 Mar;45(3):964-70
14985318
Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3292-8
12356837
Vet Ophthalmol. 2002 Jun;5(2):103-6
12071867
Nature. 2000 Jul 13;406(6792):195-9
10910361